Wells Fargo analyst James Feldman raised the firm’s price target on Omega Healthcare to $40 from $35 and keeps an Overweight rating on the shares. The firm offered updated thoughts on Healthcare REITs following Q2 earnings from the group, saying it is maintains a favorable view on Healthcare as a weaker jobs report and lower end consumer point to easing labor costs, which should drive better metrics. The firm is also encouraged the equity market is open for investment capital, the analyst tells investors in the sector note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare raises FY24 adjusted FFO view to $2.78-$2.84 from $2.70-$2.80
- Omega Healthcare reports Q2 adjusted FFO 71c, consensus 69c
- OHI Upcoming Earnings Report: What to Expect?
- Omega Healthcare downgraded to Neutral from Outperform at Mizuho
- Omega Healthcare price target raised to $33 from $32 at Scotiabank